Profile
| Metric | Value |
|---|---|
| Full Name | Tandem Diabetes Care, Inc. |
| Ticker | NASDAQ: TNDM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tandemdiabetes.com |
| Employees | 2,650 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $22.50 | |
| Price, 1D Change | -0.92% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.17 | |
| Revenue | $940M | |
| Revenue, 1Y Change | +25.74% | |
| EPS | -$1.47 | |
| EPS, 1Y Change | +57.18% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.47 | |
| EPS Estimate | -$2.17 | |
| EPS Est. Change | -47.67% | |
| Revenue | $940.20M | |
| Revenue Estimate | $1.00B | |
| Revenue Est. Change | +6.49% | |
| Current Price | $22.50 | |
| Price Target | - | $22.00 |
| Price Tgt. Change | - | -2.22% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.55 | -$3.43 | -121.06% | |
| -$1.72 | -$1.47 | +14.58% | |
| -$2.17 | N/A | -47.67% | |
| -$0.97 | N/A | +33.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $762.98M | $747.72M | -2.00% | |
| $909.33M | $940.20M | +3.40% | |
| $1.00B | N/A | +6.49% | |
| $1.10B | N/A | +17.00% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -39.98% | |
| Price, 3Y | -50.13% | |
| Market Cap, 1Y | -38.59% | |
| Market Cap, 3Y | -47.59% | |
| Revenue, 1Y | +25.74% | |
| Revenue, 3Y | +33.78% | |
| EPS, 1Y | +57.18% | |
| EPS, 3Y | -706.49% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $22.50 | |
| SMA 200 | $17.30 | |
| SMA 200 vs Price | -23.09% | |
| SMA 50 | $19.82 | |
| SMA 50 vs Price | -11.91% | |
| Beta | 1.17 | |
| ATR | $1.04 | |
| 14-Day RSI | 56.32 | |
| 10-Day Volatility | 47.90% | |
| 1-Year Volatility | 74.86% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $940.20M | |
| EPS | -$1.47 | |
| Gross Profit | $489.57M | |
| Gross Margin | 50.51% | |
| Operating Profit | -$99.13M | |
| Operating Margin | -10.54% | |
| Net Income | -$96.03M | |
| Net Margin | -10.21% | |
| EBITDA | -$69.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.80 | |
| Current Ratio | 2.93 | |
| Quick Ratio | 2.33 | |
| Interest Coverage | -15.68 | |
| F-Score | 3 | |
| Altman Z-Score | 1.05 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 1.51 | |
| PB Ratio | 11.47 | |
| EV/EBITDA | -20.50 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $263.10M | |
| Cash & Equivalents | $69.23M | |
| Total Assets | $967.66M | |
| Current Assets | $724.49M | |
| Total Liabilities | $704.56M | |
| Current Liabilities | $247.05M | |
| Total Debt | $473.57M | |
| Short Term Debt | $58.88M | |
| Accounts Payable | $44.73M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.04B | |
| Operating Expenses | $588.70M | |
| Cost Of Goods Sold | $465.34M | |
| SG&A | $389.82M | |
| D&A | $16.61M | |
| Interest Expense | $5.51M | |
| Income Tax | $4.16M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $24.23M | |
| CFI | -$23.48M | |
| CFF | $8.37M | |
| Capex | $19.23M | |
| Free Cash Flow | -$41.41M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Truist Securities | → | |
| Mizuho | → | |
| Canaccord Genuity | → | |
| Baird | → | |
| Citigroup | → | |
| Morgan Stanley | → | |
| Truist Securities | → | |
| Morgan Stanley | → | |
| Barclays | → | |
| Wells Fargo | → |
Analyst sentiment
Institutional ownership
Screeners with TNDM
Data Sources & References
- TNDM Official Website www.tandemdiabetes.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1438133/000143813325000187/0001438133-25-000187-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1438133/000143813325000036/0001438133-25-000036-index.htm
- TNDM Profile on Yahoo Finance finance.yahoo.com/quote/TNDM
- TNDM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tndm
FAQ
What is the ticker symbol for Tandem Diabetes Care, Inc.?
The ticker symbol for Tandem Diabetes Care, Inc. is NASDAQ:TNDM
Does Tandem Diabetes Care, Inc. pay dividends?
No, Tandem Diabetes Care, Inc. does not pay dividends
What sector is Tandem Diabetes Care, Inc. in?
Tandem Diabetes Care, Inc. is in the Healthcare sector
What industry is Tandem Diabetes Care, Inc. in?
Tandem Diabetes Care, Inc. is in the Medical Devices industry
What country is Tandem Diabetes Care, Inc. based in?
Tandem Diabetes Care, Inc. is headquartered in United States
When did Tandem Diabetes Care, Inc. go public?
Tandem Diabetes Care, Inc. initial public offering (IPO) was on November 14, 2013
Is Tandem Diabetes Care, Inc. in the S&P 500?
No, Tandem Diabetes Care, Inc. is not included in the S&P 500 index
Is Tandem Diabetes Care, Inc. in the NASDAQ 100?
No, Tandem Diabetes Care, Inc. is not included in the NASDAQ 100 index
Is Tandem Diabetes Care, Inc. in the Dow Jones?
No, Tandem Diabetes Care, Inc. is not included in the Dow Jones index
When was Tandem Diabetes Care, Inc. last earnings report?
Tandem Diabetes Care, Inc.'s most recent earnings report was on November 6, 2025
When does Tandem Diabetes Care, Inc. report earnings?
The next expected earnings date for Tandem Diabetes Care, Inc. is February 25, 2026